围手术期避免低血压策略与避免高血压策略对术后急性肾损伤风险的影响:POISE-3试验子研究
该研究为POISE-3试验预设子研究,纳入7307例45岁以上、有动脉粥样硬化疾病或风险、服用至少一种降压药并接受非心脏手术的患者,比较围手术期避免低血压策略(目标术中平均动脉压≥80 mmHg,手术日及术后两天停用肾素-血管紧张素-醛固酮系统抑制剂,收缩压≥130 mmHg时逐步使用其他降压药)与避免高血压策略(目标术中平均动脉压≥60 mmHg,围手术期继续所有降压药)对术后急性肾损伤风险的影响。结果显示两组急性肾损伤风险无显著差异(15.1% vs 14.4%),其他急性肾损伤定义及已有慢性肾脏病患者中结果一致。
要点
- 避免低血压策略未降低术后急性肾损伤风险。
- 两组急性肾损伤发生率分别为15.1%和14.4%。
- 在已有慢性肾脏病患者中结果一致。
核心结论
- 围手术期避免低血压策略(目标术中平均动脉压≥80 mmHg并停用降压药)与避免高血压策略相比,未降低术后急性肾损伤风险。
研究设计与样本
- POISE-3随机试验的预设子研究,纳入110家医院、22个国家的7307例患者。
- 患者年龄≥45岁,有动脉粥样硬化疾病或风险,服用至少一种降压药,接受非心脏手术。
主要发现
- 避免低血压组(3654例)与避免高血压组(3653例)术后急性肾损伤风险无显著差异(15.1% vs 14.4%)。
- 避免低血压组手术日使用ACEI或ARB者占6%,避免高血压组占38%;术后第1天分别为6% vs 47%,第2天为7% vs 50%。
- 避免低血压组术中平均动脉压低于80 mmHg的时间约为避免高血压组的一半(27 vs 60分钟)。
- 结果与其他急性肾损伤定义及已有慢性肾脏病患者中一致。
关键数值与推荐
- 避免低血压策略:术中目标平均动脉压≥80 mmHg;手术日及术后两天停用肾素-血管紧张素-醛固酮系统抑制剂,收缩压≥130 mmHg时逐步使用其他降压药。
- 避免高血压策略:术中目标平均动脉压≥60 mmHg;围手术期继续所有降压药。
- 主要结局:术后急性肾损伤,定义为随机化后48小时内血清肌酐升高≥26.5 μmol/L(0.3 mg/dL)或随机化后7天内升高≥50%。
临床怎么用
- 对于接受非心脏手术且有动脉粥样硬化疾病或风险的患者,围手术期以避免低血压为目标(术中平均动脉压≥80 mmHg)并停用降压药,并未显示可降低术后急性肾损伤风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this pre-specified sub-study of the POISE-3 trial, we examined the effect of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of postoperative acute kidney injury (AKI). Altogether, 7307 patients were included from 110 hospitals in 22 countries. Patients were 45 years and older, had or were at risk of atherosclerotic disease, took at least one antihypertensive medication, and were scheduled for noncardiac surgery. Hypotension-avoidance strategy: (i) target intraoperative mean arterial pressure (MAP) 80 mm Hg or over, (ii) on day of surgery and for two days after, hold renin-angiotensin-aldosterone system inhibitors and use other antihypertensives in stepwise fashion if systolic blood pressure (SBP) 130 mm Hg or more. Hypertension-avoidance strategy: (i) target intraoperative MAP 60 mm Hg or more, (ii) continue all antihypertensives before and after surgery. Primary outcome: postoperative AKI, an increase in serum creatinine concentration of either 26.5 μmol/L or more (0.3 mg/dL or more) within 48 hours of randomization or 50% or more within seven days of randomization. The hypotension-avoidance group (3654 patients) used fewer antihypertensive medications than the hypertension-avoidance group (3653 patients); specifically, 6% vs. 38% used an ACEI or ARB on the day of surgery, and 6% vs. 47% and 7% vs. 50% one and two days after surgery, respectively. Patients also spent about half as much intraoperative time with a MAP under 80 mm Hg (27 vs. 60 minutes, respectively), but had little difference in average BP before or after surgery. There was no significant difference in AKI risk (15.1% vs. 14.4%). Results were consistent with other definitions of AKI and in patients with preexisting chronic kidney disease. Thus, a hypotension-avoidance strategy targeting a MAP greater than 80 mm Hg in the operating room and discontinued blood pressure medication during the perioperative period did not confer a lower risk of AKI compared to a hypertension avoidance strategy. Clinical trial registration number: NCT03505723.
引用
- A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury. Kidney Int. 2024. PMID: 39490985. doi:10.1016/j.kint.2024.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。